Advanced Oncotherapy (AVO) has announced further delays to its recapitalisation plans. The proton beam therapy developer had been expecting an initial tranche of funding in the region of $15m from a new investor in February following delays, but said this had not been received and it was now expecting the deal to go ahead this…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2024 All rights reserved LaingBuisson 
 has announced further delays to its recapitalisation plans.){kind=link}